MS
BMY icon

Marshall & Sullivan’s Bristol-Myers Squibb BMY Stock Holding History

Marshall & Sullivan’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-200
Closed -$9K – 50
2014
Q2 		$9K Buy
+200
New +$9.86K 0.02% 61

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Marshall & Sullivan's BMY Position: Q3 2014 in Review

Marshall & Sullivan sold out of Bristol-Myers Squibb (BMY) in Q3 2014, closing a stake of 200 shares — an estimated $9K sold.

Marshall & Sullivan first reported a position in BMY in Q2 2014 and held it in 1 quarter. The position peaked at $9K in Q2 2014. 1,303 funds tracked by Wall St. Rank hold BMY as of Q3 2014.

  • Marshall & Sullivan reported no remaining Bristol-Myers Squibb position as of Q3 2014 after selling out during the quarter.
  • Marshall & Sullivan sold 200 Bristol-Myers Squibb shares in Q3 2014, an estimated $9K.
  • Marshall & Sullivan first reported a position in Bristol-Myers Squibb in Q2 2014 and held it in 1 quarter.
  • Marshall & Sullivan's Bristol-Myers Squibb position peaked at $9K in Q2 2014.
  • 1,303 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2014.

Based on Marshall & Sullivan's 13F filing for Q3 2014, filed 14 Nov 2014.